Search Results for

Clear All Filters

April 16, 2021

Fatou Ndiaye Zena Wolf

Blog Post

CoronavirusExecutive BranchIntellectual PropertyRevolving Door

The Brother Of A Pharma Lobbyist Advises Biden As He Weighs Vaccine IP Waiver

Despite pushback from progressives, Ricchetti has continued to hold a powerful advisory position in the Biden White House. His background in corporate lobbying and strong ties to the pharmaceutical industry are deeply troubling signs as the Biden Administration faces enormously consequential decisions about how to end the COVID-19 pandemic.

April 15, 2021

Timi Iwayemi

Blog Post

Foreign PolicyIntellectual Property

Why Is Politico's Ryan Heath Carrying Water For Big Pharma Monopolies?

The world is currently at an inflection point – Western leaders can choose to continue blocking the TRIPS waiver and lock in a cycle of dependence or empower poorer countries to develop generic vaccines and build infrastructure that will safely put the pandemic behind us. Critiques of the TRIPS waiver claim that most poor countries lack the infrastructure to carry out vaccine operations – a paternalistic view that suggests that manufacturing capacity, supply chain management, and logistics are static in nature. The sooner we act, the more time poorer countries have to begin mobilizing resources needed to make generic vaccine development possible.

April 09, 2021

Eleanor Eagan Timi Iwayemi

Blog Post

Department of CommerceIntellectual Property

Why You Should Care Who Leads the Patent and Trademark Office

As pressure mounts on the United States government to support waiving intellectual property (IP) protections on the COVID-19 vaccines at the World Trade Organization, progressives are closely monitoring the Biden administration’s appointments to agencies that impact intellectual property matters such as the United States Patent and Trademark Office (USPTO).

April 08, 2021

Sion Bell

Blog Post

CoronavirusDepartment of CommerceIntellectual Property

Secretary Raimondo Must Act Quickly to Support the TRIPS Waiver

As the Biden administration continues to tackle the Covid-19 pandemic, Commerce Secretary Gina Raimondo holds one of the most critical but under-appreciated roles for ensuring vaccine distribution. Indeed, the Commerce Secretary is a key player determining more generally whether America and the planet prioritize Big Pharma’s wealth or public health.